Ionis Pharmaceuticals, Inc.
LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

Abstract:

The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group.